Frazier Life Sciences Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32M	Buy	1,438,198 +141,000	+11%	+$3.37M	0.82%	24
2025 Q4	$34.6M	Buy	1,297,198 +683,361	+111%	+$16.3M	0.93%	23
2025 Q3	$13.1M	Buy	+613,837	New	+$14.5M	0.39%	36
2025 Q2	–	Sell	-470,338	Closed	-$7.81M	–	50
2025 Q1	$7.81M	Hold	470,338	–	–	0.36%	34
2024 Q4	$8.63M	Hold	470,338	–	–	0.36%	38
2024 Q3	$7.23M	Hold	470,338	–	–	0.29%	45
2024 Q2	$7.64M	Hold	470,338	–	–	0.36%	40
2024 Q1	$8.7M	Sell	470,338 -260,579	-36%	-$6.46M	0.37%	42
2023 Q4	$22.9M	Buy	730,917 +100,020	+16%	+$2.39M	1.22%	23
2023 Q3	$13.1M	Sell	630,897 -226,441	-26%	-$6.15M	0.87%	29
2023 Q2	$20.5M	Hold	857,338	–	–	1.23%	20
2023 Q1	$16.1M	Hold	857,338	–	–	1.17%	23
2022 Q4	$13.6M	Hold	857,338	–	–	0.85%	23
2022 Q3	$14M	Buy	+857,338	New	+$13.9M	1.08%	22